Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in AVLN — Avalyn Pharma Inc.

CIK 1214717 BOSTON, MA
Back to AVLN Full portfolio

Position in AVLN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$14,308,677
New position
Shares Held
434,650
first reported quarter
Ownership
0.980%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 92 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. AVLN ranks #162 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in AVLN

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $14,308,677 434,650